Method of reducing tissue damage associated with non-cardiac isc

Details Method of reducing tissue damage associated with non-cardiac isc Method of reducing tissue damage associated with non-cardiac isc

1997-11-25

1999-09-14

Reamer, James H.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514323, 514414, 514419, A61K 31395

Patent

active

059523220

ABSTRACT:
A method of preventing non-cardiac tissue damage resulting from ischemia and/or hypoxia, comprising administering to a patient in need of such treatment an effective amount of an glycogen phosphorylase inhibitor.

REFERENCES:
patent: 4879283 (1989-11-01), Belzer et al.
patent: 5266561 (1993-11-01), Cooper et al.
patent: 5281581 (1994-01-01), Cooper et al.
patent: 5395822 (1995-03-01), Izumi et al.
patent: 5541218 (1996-07-01), Ikeda et al.
patent: 5635527 (1997-06-01), Ono et al.
patent: 5723449 (1998-03-01), Sommadossi et al.
T. Blundell et al., Structural biology and diabetes mellitus: molecular pathogenesis and rational drug design, Diabetologia, (1992) 35, Suppl 2, pp. S69-S76.
Peter J. Kasvinsky et al., The Regulation of Glycogen Phosphorylase .alpha. by Nucleotide Derivatives, The Journal of Biological Chemistry vol. 253, No. 9. Issue of May 10, 1978, pp. 3343-3351.
J. L. Martin et al., Glucose Analogue Inhibitors of Glycogen Phosphorylase: The Design of Potential Drugs for Diabetes, Biochemistry, 1991, vol. 30, No. 42, pp. 10101-10116.
Peter J. Kasvinsky et al., Synergistic Regulation of Phosphorylase .alpha. by Glucose and Caffeine*, The Journal of Biological Chemistry, vol. 253, No. 24, Issue of Dec. 25, 1978, pp. 9102-9106.
Christopher B. Newgard et al., Cloning, Sequence Analysis, Chromosomal Mapping, Tissue Expression, and Comparison with the Human Liver and Muscle Isozymes, The Journal of Biological Chemistry, vol. 263, No. 8, Mar. 15, 1988, pp. 3850-3857.
J. H. Weil, "Biochimie Generale", Masson and Cie ed., "II. Degradation du glycogene. (Glycogenolyse)", 1975, p. 175, p. 176, p. 181.
Raymond A. Swanson et al., Regional brain glycogen stores and metabolism during complete global ischaemia, Neurological Research, 1989, vol. 11, Mar., pp. 24-28.
Christine Marie, Fasting Prior to Transient Cerebral Ischemia Reduces Delayed Neuronal Necrosis, Metabolic Brain Disease, vol. 5 No. 2, 1990, pp. 66-75.
Wole, Christopher L. et al., Loss of Myocardial Protection Ater Preconditioning Correlates With the Time Course of Glycogen Recovery Within the Preconditioned Segment, Circulation, , vol. 87, No. 3, Mar. 1993, pp. 881-892.
Allard, M. F. et al., Preischemic glycogen reduction of glycolytic inhibition improves postischemic recovery of hypertrophied rate hearts, American Physiological Society, 1994, pp. H66-H74.

Affiliated with

Also associated with

Rating

Method of reducing tissue damage associated with non-cardiac isc does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of reducing tissue damage associated with non-cardiac isc, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of reducing tissue damage associated with non-cardiac isc will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1509887